Chapter 12 - Personalized psychiatry with human iPSCs and neuronal reprogramming

Cedric Bardy, Zarina Greenberg, Seth W. Perry, Julio Licinio

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In little more than a decade since their first reported use and methodological discovery, human induced pluripotent stem cells (iPSCs) have provided exceptional new progress and opportunities for understanding psychiatric disease from an individualized perspective. In this chapter, we discuss the application of iPSCs to personalized psychiatry, beginning with an overview of iPSC technology and methods, and challenges and opportunities for their application in personalized medicine, including therapeutics development, individualized prediction of drug response, and potential identification of individually unique disease mechanisms or genetics. Next, we review how iPSC technologies have thus far been used to model and better understand psychiatric diseases, with a focus on bipolar disorder, depression and major depressive disorder, schizophrenia, and autism spectrum disorder. Finally, we finish by addressing what we consider to be the key needs and opportunities for maximizing the impact of iPSC research and technology on personalized psychiatry.
LanguageEnglish
Title of host publicationPersonalized Psychiatry
EditorsBernhard T. Baune
Place of PublicationSan Diego
PublisherAcademic Press
Pages127-146
Number of pages20
ISBN (Print)978-0-12-813176-3
DOIs
Publication statusPublished - 25 Oct 2019

Keywords

  • Precision medicine
  • Personalized medicine
  • Personalized psychiatry
  • Brain disorders
  • Induced pluripotent stem cell
  • Cell reprogramming
  • Depression
  • Bipolar
  • Schizophrenia
  • Autism

Cite this

Bardy, C., Greenberg, Z., Perry, S. W., & Licinio, J. (2019). Chapter 12 - Personalized psychiatry with human iPSCs and neuronal reprogramming. In B. T. Baune (Ed.), Personalized Psychiatry (pp. 127-146). San Diego: Academic Press. https://doi.org/10.1016/B978-0-12-813176-3.00012-2
Bardy, Cedric ; Greenberg, Zarina ; Perry, Seth W. ; Licinio, Julio. / Chapter 12 - Personalized psychiatry with human iPSCs and neuronal reprogramming. Personalized Psychiatry. editor / Bernhard T. Baune. San Diego : Academic Press, 2019. pp. 127-146
@inbook{845aafbf4f834c82af1ad9f052d74000,
title = "Chapter 12 - Personalized psychiatry with human iPSCs and neuronal reprogramming",
abstract = "In little more than a decade since their first reported use and methodological discovery, human induced pluripotent stem cells (iPSCs) have provided exceptional new progress and opportunities for understanding psychiatric disease from an individualized perspective. In this chapter, we discuss the application of iPSCs to personalized psychiatry, beginning with an overview of iPSC technology and methods, and challenges and opportunities for their application in personalized medicine, including therapeutics development, individualized prediction of drug response, and potential identification of individually unique disease mechanisms or genetics. Next, we review how iPSC technologies have thus far been used to model and better understand psychiatric diseases, with a focus on bipolar disorder, depression and major depressive disorder, schizophrenia, and autism spectrum disorder. Finally, we finish by addressing what we consider to be the key needs and opportunities for maximizing the impact of iPSC research and technology on personalized psychiatry.",
keywords = "Precision medicine, Personalized medicine, Personalized psychiatry, Brain disorders, Induced pluripotent stem cell, Cell reprogramming, Depression, Bipolar, Schizophrenia, Autism",
author = "Cedric Bardy and Zarina Greenberg and Perry, {Seth W.} and Julio Licinio",
year = "2019",
month = "10",
day = "25",
doi = "10.1016/B978-0-12-813176-3.00012-2",
language = "English",
isbn = "978-0-12-813176-3",
pages = "127--146",
editor = "Baune, {Bernhard T.}",
booktitle = "Personalized Psychiatry",
publisher = "Academic Press",

}

Bardy, C, Greenberg, Z, Perry, SW & Licinio, J 2019, Chapter 12 - Personalized psychiatry with human iPSCs and neuronal reprogramming. in BT Baune (ed.), Personalized Psychiatry. Academic Press, San Diego, pp. 127-146. https://doi.org/10.1016/B978-0-12-813176-3.00012-2

Chapter 12 - Personalized psychiatry with human iPSCs and neuronal reprogramming. / Bardy, Cedric; Greenberg, Zarina; Perry, Seth W.; Licinio, Julio.

Personalized Psychiatry. ed. / Bernhard T. Baune. San Diego : Academic Press, 2019. p. 127-146.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Chapter 12 - Personalized psychiatry with human iPSCs and neuronal reprogramming

AU - Bardy, Cedric

AU - Greenberg, Zarina

AU - Perry, Seth W.

AU - Licinio, Julio

PY - 2019/10/25

Y1 - 2019/10/25

N2 - In little more than a decade since their first reported use and methodological discovery, human induced pluripotent stem cells (iPSCs) have provided exceptional new progress and opportunities for understanding psychiatric disease from an individualized perspective. In this chapter, we discuss the application of iPSCs to personalized psychiatry, beginning with an overview of iPSC technology and methods, and challenges and opportunities for their application in personalized medicine, including therapeutics development, individualized prediction of drug response, and potential identification of individually unique disease mechanisms or genetics. Next, we review how iPSC technologies have thus far been used to model and better understand psychiatric diseases, with a focus on bipolar disorder, depression and major depressive disorder, schizophrenia, and autism spectrum disorder. Finally, we finish by addressing what we consider to be the key needs and opportunities for maximizing the impact of iPSC research and technology on personalized psychiatry.

AB - In little more than a decade since their first reported use and methodological discovery, human induced pluripotent stem cells (iPSCs) have provided exceptional new progress and opportunities for understanding psychiatric disease from an individualized perspective. In this chapter, we discuss the application of iPSCs to personalized psychiatry, beginning with an overview of iPSC technology and methods, and challenges and opportunities for their application in personalized medicine, including therapeutics development, individualized prediction of drug response, and potential identification of individually unique disease mechanisms or genetics. Next, we review how iPSC technologies have thus far been used to model and better understand psychiatric diseases, with a focus on bipolar disorder, depression and major depressive disorder, schizophrenia, and autism spectrum disorder. Finally, we finish by addressing what we consider to be the key needs and opportunities for maximizing the impact of iPSC research and technology on personalized psychiatry.

KW - Precision medicine

KW - Personalized medicine

KW - Personalized psychiatry

KW - Brain disorders

KW - Induced pluripotent stem cell

KW - Cell reprogramming

KW - Depression

KW - Bipolar

KW - Schizophrenia

KW - Autism

U2 - 10.1016/B978-0-12-813176-3.00012-2

DO - 10.1016/B978-0-12-813176-3.00012-2

M3 - Chapter

SN - 978-0-12-813176-3

SP - 127

EP - 146

BT - Personalized Psychiatry

A2 - Baune, Bernhard T.

PB - Academic Press

CY - San Diego

ER -

Bardy C, Greenberg Z, Perry SW, Licinio J. Chapter 12 - Personalized psychiatry with human iPSCs and neuronal reprogramming. In Baune BT, editor, Personalized Psychiatry. San Diego: Academic Press. 2019. p. 127-146 https://doi.org/10.1016/B978-0-12-813176-3.00012-2